Dexamethasone and the prevention of neonatal hypoxic-ischemic brain damage.
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D001925:Brain Damage, Chronic / Q000517:prevention & control*; D002545:Brain Ischemia / Q000517:prevention & control*; D002374:Catalase / Q000378:metabolism; D002544:Cerebral Infarction / Q000517:prevention & control; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000494:pharmacology; D005979:Glutathione Peroxidase / Q000378:metabolism; D006801:Humans; D002534:Hypoxia, Brain / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013482:Superoxide Dismutase / Q000378:metabolism
D005938:Glucocorticoids; D018696:Neuroprotective Agents; D003907:Dexamethasone; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase